BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12971434)

  • 1. The impact of MELD on OPTN liver allocation: preliminary results.
    Edwards EB; Harper AM
    Clin Transpl; 2002; ():21-8. PubMed ID: 12971434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of PELD on OPTN liver allocation: preliminary results.
    Davies DB
    Clin Transpl; 2003; ():13-20. PubMed ID: 15387095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of a continuous disease severity score to the OPTN liver waiting list.
    Edwards EB; Harper AM
    Clin Transpl; 2001; ():19-24. PubMed ID: 12211782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
    Tenório AL; Macedo FI; Miranda LE; Fernandes JL; da Silva CM; Neto OL; Lacerda CM
    Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
    Monteiro F; Coria SA; Boni R; Pereira LA
    Transplant Proc; 2009; 41(1):226-8. PubMed ID: 19249520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged waiting times for liver transplantation in obese patients.
    Segev DL; Thompson RE; Locke JE; Simpkins CE; Thuluvath PJ; Montgomery RA; Maley WR
    Ann Surg; 2008 Nov; 248(5):863-70. PubMed ID: 18948816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?
    Silberhumer GR; Hetz H; Rasoul-Rockenschaub S; Peck-Radosavljevic M; Soliman T; Steininger R; Muehlbacher F; Berlakovich GA
    Transpl Int; 2006 Apr; 19(4):275-81. PubMed ID: 16573542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of the MELD score and the UNOS adult liver allocation system.
    Martin AP; Bartels M; Hauss J; Fangmann J
    Transplant Proc; 2007 Dec; 39(10):3169-74. PubMed ID: 18089345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality.
    Ben-Haim M; Carmiel M; Katz P; Shabtai E; Oren R; Nakache R
    Isr Med Assoc J; 2006 Sep; 8(9):605-9. PubMed ID: 17058408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of the first year of the new liver allocation plan.
    Freeman RB; Wiesner RH; Edwards E; Harper A; Merion R; Wolfe R;
    Liver Transpl; 2004 Jan; 10(1):7-15. PubMed ID: 14755772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
    Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABO blood group-related waiting list disparities in liver transplant candidates: effect of the MELD adoption.
    Barone M; Avolio AW; Di Leo A; Burra P; Francavilla A
    Transplantation; 2008 Mar; 85(6):844-9. PubMed ID: 18360266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is MELD really the definitive score for liver allocation?
    Lladó L; Figueras J; Memba R; Xiol X; Baliellas C; Vázquez S; Ramos E; Torras J; Rafecas A; Fabregat J; Lama C; Jaurrieta E
    Liver Transpl; 2002 Sep; 8(9):795-8. PubMed ID: 12200780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model for End-Stage Liver Disease (MELD) system to allocate and to share livers: experience of two Italian centers.
    Ravaioli M; Masetti M; Dazzi A; Romano A; Spaggiari M; Grazi GL; Ercolani G; Cescon M; Di Gioia P; De Ruvo N; Montalti R; Ballarin R; Di Benedetto F; Ridolfi L; Alvaro N; Ramacciato G; Morelli C; Gerunda E; Pinna AD
    Transplant Proc; 2008; 40(6):1814-5. PubMed ID: 18675057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004).
    Shneider BL; Suchy FJ; Emre S
    Liver Transpl; 2006 Jan; 12(1):40-5. PubMed ID: 16382460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation for hepatocellular carcinoma: the MELD impact.
    Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
    Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of pediatric candidates under the PELD system.
    McDiarmid SV; Merion RM; Dykstra DM; Harper AM
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S23-30. PubMed ID: 15384170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for liver transplantation waiting list mortality.
    Fink MA; Berry SR; Gow PJ; Angus PW; Wang BZ; Muralidharan V; Christophi C; Jones RM
    J Gastroenterol Hepatol; 2007 Jan; 22(1):119-24. PubMed ID: 17201891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans.
    Ahmad J; Downey KK; Akoad M; Cacciarelli TV
    Liver Transpl; 2007 Nov; 13(11):1564-9. PubMed ID: 17969210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excellent liver transplant survival rates under the MELD/PELD system.
    Freeman RB; Harper A; Edwards EB
    Transplant Proc; 2005 Mar; 37(2):585-8. PubMed ID: 15848465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.